|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| C07K 16/22 | (2006.01) | ||
| G01N 33/53 | (2006.01) | ||
| C12N 15/68 | (2006.01) | ||
| C12N 5/10 | (2006.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 1648509 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04778409.5 |
| Date of filing the European patent application | 2004-07-15 | |
| (97) | Date of publication of the European application | 2006-04-26 |
| (45) | Date of publication and mention of the grant of the patent | 2012-09-12 |
| (46) | Date of publication of the claims translation | 2012-12-27 |
| (86) | Number | PCT/US2004/022876 |
| Date | 2004-07-15 |
| (87) | Number | WO 2005/019266 |
| Date | 2005-03-03 |
| (30) | Number | Date | Country code |
| 487431 P | 2003-07-15 | US |
| (72) |
WILD, Kenneth, D., Jr., US
TREANOR, James, J., S., US
HUANG, Haichun, US
INOUE, Heather, US
ZHANG, Tie, J., US
MARTIN, Frank, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, CA 91320-1799,
US
Medarex, Inc., Route 206 & Province Line Road, Princeton, NJ 08543, US |
| (74) |
Genė Ona SRUOGIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
| (54) | Žmogaus anti-NGF neutralizuojantys antikūnai kaip selektyvūs NGF kelio inhibitoriai |
| HUMAN ANTI-NGF NEUTRALIZING ANTIBODIES AS SELECTIVE NGF PATHWAY INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2018-06-20 | 15 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2019-07-15 |